Go Backs
HomeCategoriesStatesCheck Your Home
Go Backs

Track product recalls and safety alerts from CPSC, FDA, NHTSA, and USDA. Stay informed and keep your family safe.

Browse

  • Categories
  • States
  • Check Your Home
  • Risk Levels

Agencies

  • CPSC
  • FDA Food
  • FDA Drug
  • FDA Device
  • FDA Veterinary
  • NHTSA
  • USDA

Company

  • About
  • FAQ
  • Contact
  • Terms of Service
  • Privacy Policy

Recall data is sourced from official U.S. government agencies (CPSC, FDA, NHTSA, USDA) and processed using AI to improve readability. This site is not affiliated with or endorsed by any government agency. Always refer to the original agency notice for authoritative information.

© 2026 Go Backs. All rights reserved.

Medium RiskFDA Vet
Pets & Animals/Pet Medications

Virbac AH, Inc: Soloxine (Levothyroxine Sodium) Tablets Recalled for Missing Labels

Agency Publication Date: May 27, 2015
Share:
Sign in to monitor this recall

Summary

Virbac Animal Health is recalling 3,828 bottles of Soloxine (levothyroxine sodium) 0.2 mg tablets, a thyroid medication for dogs. Approximately 3,828 plastic bottles (250 tablets each) are affected because the medication may be missing the required label on the immediate container. Without a label, pet owners or veterinary staff cannot verify the medication name, dosage, or expiration date, which could lead to accidental misuse or medication errors. You should contact your veterinarian or pharmacist for guidance on how to handle any unlabelled bottles.

Risk

A missing label on the immediate container prevents the user from identifying the medication and dosage, which increases the risk of administering the wrong drug or strength to an animal. This can lead to ineffective treatment of thyroid conditions or potential toxicity if an incorrect dose is given.

What You Should Do

  1. Check your pet's medication for Virbac Animal Health Soloxine (Levothyroxine Sodium) 0.2 mg Tablets in 250-count plastic bottles with NDC 051311-832-25.
  2. Look for lot number 140977 with an expiration date of 08/2016 on the bottle or packaging.
  3. If you have a bottle that is missing its label or if you are unsure about the contents of a bottle from this lot, do not administer the medication to your pet.
  4. Contact your veterinarian or pharmacist immediately for guidance on how to identify your medication and to arrange for a replacement or refund.
  5. Return any unused or unlabelled product to the pharmacy or place of purchase for a refund and contact Virbac AH, Inc. for further instructions.
  6. For additional questions, contact the FDA Center for Veterinary Medicine at 1-240-402-7002.

Your Remedy Options

💰Full Refund

Contact healthcare provider and return product.

How to: Contact your healthcare provider or pharmacist for guidance. Return any unused product to the pharmacy for a refund and contact the manufacturer for further instructions.

Affected Products

Product: Virbac Animal Health Soloxine (Levothyroxine Sodium) 0.2 mg Tablets (250 tablets per bottle)
Model:
NDC 051311-832-25
Recall #: V-234-2015
Lot Numbers:
140977 (exp. date 08/2016)
Date Ranges: 08/2016

Additional Information

Agency: Food and Drug Administration (FDA)
Event ID: 71192
Status: Resolved
Manufacturer: Virbac AH, Inc
Sold By: veterinary distributors; pharmacies
Manufactured In: United States
Units Affected: 3,828 /250 tablets/ bottles
Distributed To: Nationwide

Were You Affected by This Recall?

If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.

Find an Attorney

This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.

AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.

Sources: FDA iRES · Raw API Response